It's a weird one out there right now. As the resume of Trump tariffs looms large over the market, Peter Switzer and Paul Rickard look at everything from Telix (TLX) to ProMedicus (PME), Virgin (VGN) to Qantas (QAN), and explain why your ETFs and trusts might look a little weird right now on the charts.
It's a weird one out there right now. As the resume of Trump tariffs looms large over the market, Peter Switzer and Paul Rickard look at everything from Telix (TLX) to ProMedicus (PME), Virgin (VGN) to Qantas (QAN), and explain why your ETFs and trusts might look a little weird right now on the charts.
Join Peter Switzer and Paul Rickard for the latest live episode of Mad about Money.
Peter Switzer speaks to Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard from Switzer.
Dr Ross Walker discusses research on basal cell cancer treatment that is similar to the COVID-19 vaccine.
Prime Value Asset Management's ST Wong, Morgans' Raymond Chan, Century 21's Charles Tarbey and Coolabah Capital's Ying Yi Ann Cheng join Peter Switzer.
Peter Switzer and Paul Rickard discuss the big money stories of the day and how they will affect you.
Peter Switzer speaks to Graham Kelly, the founder, CEO and managing director of Noxopharm (NOX).
Burman Invest's Julia Lee, Tribeca's Jun Bei Liu, Switzer's Paul Rickard and Spacetalk's Mark Fortunatow join the show.
Last week Dr Ross told us what happens when diabetics have coffee and tea every day, but what are the benefits for non-diabetics?
Peter Switzer is joined by Michael Wayne from Medallion Financial Group, Kieran Davies from Coolabah Capital and James Symond from Aussie Home Loans.
Join Peter Switzer and Paul Rickard for our latest live episode of Mad about Money.
Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard join Peter Switzer.
Peter Switzer is joined by Philip Daffas, the CEO and Managing Director of Painchek (PCK).
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox
